Evidence map›Paper›PMID 37239947›Full record

ReviewInternational journal of molecular sciences2023

TRPV3 Ion Channel: From Gene to Pharmacology.

Aleksandr P Kalinovskii, Lyubov L Utkina, Yuliya V Korolkova, Yaroslav A Andreev

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Determinants for Activation of the Ion Channel TRPV3 by Weak Acids.International journal of molecular sciences · 2025
    Article
  5. Papillomavirus-like particles as vectors forMolecular therapy. Nucleic acids · 2025
    Article
  6. Article
  7. TRPV3 in skin thermosensation and temperature responses.The journal of physiological sciences : JPS · 2025
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Aleksandr P KalinovskiiDepartment of Molecular Neurobiology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences (IBCh RAS), 16/10 Miklukho-Maklay Str., 117997 Moscow, Russia.ORCID 0000-0002-5180-2906
Lyubov L UtkinaInstitute of Molecular Medicine, Sechenov First Moscow State Medical University, Trbetskaya Str. 8, Bld. 2, 119991 Moscow, Russia.
Yuliya V KorolkovaDepartment of Molecular Neurobiology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences (IBCh RAS), 16/10 Miklukho-Maklay Str., 117997 Moscow, Russia.ORCID 0000-0001-8556-5366
Yaroslav A AndreevDepartment of Molecular Neurobiology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences (IBCh RAS), 16/10 Miklukho-Maklay Str., 117997 Moscow, Russia.ORCID 0000-0002-7628-0980
Institute of Bioorganic Chemistry · RUSechenov University · RU

Funding

Russian Science Foundation 22-25-00136
6 · The paper itself

Abstract

Transient receptor potential vanilloid subtype 3 (TRPV3) is an ion channel with a sensory function that is most abundantly expressed in keratinocytes and peripheral neurons. TRPV3 plays a role in Ca

Indexed as

PruritusSkin DiseasesHumansIon ChannelsKeratinocytesSkinTRPV Cation ChannelsIon ChannelsTRPV3 protein, humanTRPV Cation Channelsdermatitishair growthitchligandsnormal and pathological conditionspainskin regenerationtherapeuticsTRPV3

Identifiers

PMID37239947
PMCPMC10218142
OpenAlexW4376279293

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.